Journal
DRUG DISCOVERY TODAY
Volume 24, Issue 1, Pages 57-68Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2018.09.015
Keywords
-
Categories
Funding
- Innovative Medicines Initiative 2 Joint Undertaking [115966]
- European Union
- EFPIA
Ask authors/readers for more resources
Industry, regulators, health technology assessment (HTA) bodies, and payers are exploring the use of patient preferences in their decision making processes. In general, experience in conducting and assessing patient preference studies is limited. Here, we performed a systematic literature search and review to identify factors and situations influencing the value of patient preference studies, as well as applications throughout the medical product lifecyle. Factors and situations identified in 113 publications related to the organization, design, and conduct of studies, and to communication and use of results. Although current use of patient preferences is limited, we identified possible applications in discovery, clinical development, marketing authorization, HTA, and postmarketing phases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available